08/30/2024 3:47 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:23 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 3:08 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 10:47 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 8:52 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:17 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 2:34 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/30/2024 2:25 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:06 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:05 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 11:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024 12:16 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 9:27 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 9:23 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 3:09 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:11 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 8:54 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 8:56 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:11 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 12:56 PM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 12:38 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 9:50 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024 10:48 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:08 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 9:05 AM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 9:51 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 12:13 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 3:21 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 12:45 PM | SACHS BRUCE I (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 2:32 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024 11:20 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:41 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 10:50 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024 7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024 7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024 3:05 PM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 9:07 AM | Bhatia Sangeeta N. (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024 3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9365&Placement=NativeDisplay&Source=NativeDisplay) Claim Exclusive 100% Bonus: $0.25/Share |
04/16/2024 3:56 PM | Arjuna Capital (Filed by) Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024 3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024 6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024 4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject) Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024 11:14 AM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/04/2024 3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024 3:44 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:37 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 3:24 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 12:19 PM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:25 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 10:10 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:44 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 9:26 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 3:28 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:43 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:49 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:38 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:26 PM | Bozic Carmen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:29 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 10:38 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:44 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:52 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 9:16 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:50 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:43 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:03 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 10:29 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:57 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:32 AM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 9:22 AM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 10:19 AM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 4:11 PM | Sanna Bastiano (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 4:34 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:23 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 12:42 PM | Biller Jonathan (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 12:24 PM | Atkinson Edward Morrow III (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 11:44 AM | Arbuckle Stuart A (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 10:32 AM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 9:32 AM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 8:52 AM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 5:19 PM | Capital World Investors (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 3:38 PM | Kewalramani Reshma (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:40 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:43 PM | Sachdev Amit (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9365&Placement=NativeDisplay&Source=NativeDisplay) Claim Exclusive 100% Bonus: $0.25/Share |
02/08/2024 3:45 PM | Tatsis Ourania (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:47 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:20 PM | Ambrose Kristen (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:10 PM | ALTSHULER DAVID (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:09 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2024 3:06 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 3:56 PM | LEIDEN JEFFREY M (Reporting) Vertex Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 3:17 PM | Vertex Pharmaceuticals (Issuer) WAGNER CHARLES F JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 9:32 AM | Vertex Pharmaceuticals (Subject) WAGNER CHARLES F JR (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |